Medico Remedies Ltd on Saturday said the company has completed its trial production rounds at the newly established state-of-the-art ointment manufacturing plant at Palghar in Maharashtra.
The new manufacturing facility, measuring 15,000 square feet, has been constructed adjacent to the existing plant which manufactures tablets and other medicines, the company said in an exchange filing
The facility will have the capacity to manufacture up to 3 million tubes monthly, it said.
Haresh Mehta, chairman and whole-time director of the company, said the new facility would be able to cater to the fast-growing ointment industry, which is growing at 17 percent year-on-year basis. This new facility is revised schedule M-compliant and plans to apply for WHO GMP certification soon.
"We are in advanced talks with multiple global players for manufacturing these products. We intend to apply for UK MHRA, US FDA, and PIC/S certifications in the future for this plant. This will allow the company to enter regulated markets like the USA, Europe, etc," he added.
Medico is a formulation manufacturing company with a focus on anti-infective, BetaLactums, cephalosporin, antimalarial, antiretroviral, anti-ulcer drugs and antacids, vitamins, haematinics, and other supplements.
Check out our in-depth Market Coverage, Business News & get real-time Stock Market Updates on CNBC-TV18. Also, Watch our channels CNBC-TV18, CNBC Awaaz and CNBC Bajar Live on-the-go!
Lok Sabha Election 2024: Phase 5 voting concludes with over 57% voter turnout, experts weigh in on key battles
May 20, 2024 11:07 PM
BJP holds meeting in Delhi as polling underway for 5th phase
May 20, 2024 4:21 PM
UP Police arrests man after viral videos shows him voting multiple times
May 20, 2024 2:18 PM